BlackRock Fund Advisors’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.72M | Sell |
10,084
-4,658
| -32% | -$1.26M | ﹤0.01% | 3104 |
|
|
2016
Q3 | $5.84M | Buy |
14,742
+750
| +5% | +$297K | ﹤0.01% | 2777 |
|
|
2016
Q2 | $4.85M | Buy |
13,992
+2,132
| +18% | +$739K | ﹤0.01% | 2830 |
|
|
2016
Q1 | $9.86M | Buy |
11,860
+421
| +4% | +$350K | ﹤0.01% | 2357 |
|
|
2015
Q4 | $12M | Sell |
11,439
-904
| -7% | -$946K | ﹤0.01% | 2341 |
|
|
2015
Q3 | $9.69M | Buy |
12,343
+607
| +5% | +$476K | ﹤0.01% | 2386 |
|
|
2015
Q2 | $15.4M | Buy |
11,736
+2,905
| +33% | +$3.82M | ﹤0.01% | 2269 |
|
|
2015
Q1 | $18M | Buy |
8,831
+512
| +6% | +$1.04M | ﹤0.01% | 2127 |
|
|
2014
Q4 | $16M | Buy |
8,319
+1,211
| +17% | +$2.33M | ﹤0.01% | 2188 |
|
|
2014
Q3 | $5.83M | Buy |
7,108
+31
| +0.4% | +$25.4K | ﹤0.01% | 2660 |
|
|
2014
Q2 | $6.83M | Buy |
7,077
+275
| +4% | +$265K | ﹤0.01% | 2650 |
|
|
2014
Q1 | $7.36M | Buy |
6,802
+489
| +8% | +$529K | ﹤0.01% | 2585 |
|
|
2013
Q4 | $5.6M | Buy |
6,313
+3,896
| +161% | +$3.45M | ﹤0.01% | 2754 |
|
|
2013
Q3 | $2.74M | Buy |
2,417
+548
| +29% | +$620K | ﹤0.01% | 3069 |
|
|
2013
Q2 | $2.2M | Buy |
+1,869
| New | +$2.2M | ﹤0.01% | 3076 |
|